Cargando…
Safety and efficacy of peptide receptor radionuclide therapy with (177)Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors
Rationale: This study aimed to assess the safety, efficacy, and survival of (177)Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors (NETs). Methods: Thirty patients with metastatic NETs were prospectively enrolled and treated with (177)Lu-DOTA-EB-TATE (3 intended cycles at 8 to 12-wee...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516233/ https://www.ncbi.nlm.nih.gov/pubmed/36185603 http://dx.doi.org/10.7150/thno.77219 |